DC Circ. Revives Part Of Fight Over Braille-Free Drug Label
By Bonnie Eslinger · August 18, 2026, 10:17 PM EDT
The D.C. Circuit on Tuesday partially vacated a lower court judgment that had upheld the U.S. Food and Drug Administration's approval of a label without braille for Teva Pharmaceuticals' generic version...
To view the full article, register now.